Komal Jhaveri, MD, Memorial Sloan Kettering Cancer Center and lead author of the EMBER-3 trial, as she discusses the significance of this approval, its impact on the treatment…
Sung-Bae Kim, MD, PhD, Asan Medical Center, Seoul, South Korea, reports on results from the East Asian subgroup of the Phase 3 EMBER‑3 trial, showing that in patients…
NEW YORK (Reuters Health) – For patients with a hematocrit nadir of 24%-30% following percutaneous coronary intervention (PCI), the benefits of blood transfusion are unlikely to outweigh the…
The American College of Physicians (ACP) has issued recommendations for the treatment of erectile dysfunction (ED). ACP strongly recommends that physicians initiate therapy with an oral phosphodiesterase type…
NEW YORK (Reuters Health) – The results of a systematic review suggest that use of an ACE inhibitor reduces total mortality and the risk of nonfatal MI in…
NEW YORK (Reuters Health) – Elevated levels of high-sensitivity C-reactive protein (hsCRP), an inflammatory marker, predicted mortality and myocardial infarction but not stroke in a multiethnic cohort. “Our…
NEW YORK (Reuters Health) – Patients with severe cases of novel H1N1 influenza virus infection (swine flu) are at heightened risk for chest complications, including pulmonary emboli, Michigan…
The following webcasts feature experts in the field of venous thromboembolism (VTE) prevention. Topics cover several aspects of VTE prevention today, including VTE prevalence, patient risk factors, the…
The following webcasts feature experts in the field of venous thromboembolism (VTE) prevention. Topics cover several aspects of VTE prevention today, including VTE prevalence, patient risk factors, the…
The following webcasts feature experts in the field of venous thromboembolism (VTE) prevention. Topics cover several aspects of VTE prevention today, including VTE prevalence, patient risk factors, the…
The following webcasts feature experts in the field of venous thromboembolism (VTE) prevention. Topics cover several aspects of VTE prevention today, including VTE prevalence, patient risk factors, the…
